Relmada Therapeutics, Inc. (RLMD)

Unlocking innovative treatments for the improvement of human health

News

View all news

News - Jul 15, 2025

Relmada Therapeutics Appoints Renowned Urologic Oncologist, Yair Lotan, MD, to Chair the Clinical Advisory Board and Support Development of NDV-01

News - Jun 17, 2025

Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology

News - May 12, 2025

Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Events

View all events

Event - May 23, 2025 9:30 AM EDT

2025 Annual Meeting of Stockholders

Read more

Event - May 12, 2025 4:30 PM EDT

Q1 2025 Financial Results Conference Call

Read more

Event - Apr 28, 2025 4:30 PM EDT

Virtual KOL Event

Read more